Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Alerts
    4. Protect your heart: Purely diagnostic heart monitoring device found to be patent eligible subject matter

      Alerts

    Alert / Intellectual Property

    Protect your heart: Purely diagnostic heart monitoring device found to be patent eligible subject matter

    May 8, 2020

    LinkedInX (Twitter)EmailCopy URL

    By Daniel Schwartz and Vincent Capati

    On April 17, the Federal Circuit held that a purely diagnostic heart monitoring device is patent eligible subject matter—adding to the short list of precedents that have found claims covering an algorithm for monitoring and analyzing data to be patentable. The court reasoned that a device that detects a patient’s cardiac events is patentable under 35 U.S.C. § 101 if the device is a technological improvement and does not merely automate longstanding techniques.[1]

    Cardionet’s patent claimed a cardiac monitoring system for detecting and distinguishing atrial fibrillation and flutter from other arrhythmias.[2] Specifically, the patent claimed: (1) a “beat detector” to identify timing between beats and premature ventricular beats, (2) “logic” to determine variability in relevant beat timing (to distinguish ventricular tachycardic beats), and (3) an event generator for when atrial fibrillation or flutter is identified.[3] The Federal Circuit reversed the district court’s grant of a motion to dismiss for patent ineligible subject matter.

    The Federal Circuit determined that the claims focused on “a specific means or method that improves cardiac monitoring technology.”[4] The improvement in technology cited by the court related specifically to the process for analyzing beat-to-beat timing in cardiac data to identify a type of atrial fibrillation more reliably.[5] The court confirmed that the claims could not have been an automation of known techniques because “it is difficult to fathom how doctors mentally or manually used logic to identify the relevance of the variability in the beat-to-beat timing using a non-linear function of a beat-to-beat interval.”[6]

    The Federal Circuit further pointed to statements in the written description to support its conclusion that the claimed subject matter was an improvement in cardiac monitoring technology. First, the device was a technological improvement for effectively avoiding false positives and false negatives in correctly identifying atrial fibrillation and flutter.[7] Second, the device is able to identify “sustained episodes of atrial fibrillation and atrial flutter that have increased clinical significance.”[8] These statements in the specification were “accepted as true and consider[ed] important in [the court’s] determination that the claims are drawn to a technological improvement.”[9] Further, there was no evidence that the “claims merely computerized pre-existing techniques for diagnosing atrial fibrillation and atrial flutter”[10] or “merely collect[ed] information, display[ed] information, or embod[ied] mental processes.”[11]

    Cardionet may clear the way for increased patenting on purely diagnostic tools because it provides a roadmap for the types of claims focusing on data analysis that are likely to be considered patentable subject matter. Cardionet’s finding that the patents claims to data processing techniques that improve diagnostic accuracy qualify as an improvement in technology under § 101 precedent may be viewed as an extension of prior eligibility case law that focused on improvements in computer technology.

    Practice Tips

    For patentees, consider drafting claim language that distinguishes the claimed device’s technique from mental or known processes, focusing on specific methods that improve a particular technology. In this case, for example, the Federal Circuit stated that “nothing in the record supports the district court’s fact finding that doctors long used the claimed diagnostic processes.”[12] The district court’s assumption that the claims are directed to automating known techniques also seems incongruous with the claimed subject matter. For example, it is difficult to fathom how doctors mentally or manually could use “logic to identify the relevance of the variability [in the beat-to-beat timing] using a non-linear function of a beat-to-beat interval” as required by claim 10.”[13] In addition, because “Step 1” of the Alice analysis requires the court to review not only the claims, but also the written description, patentees should further consider explaining how the invention improves the particular technology field. In this case, the written description “describe[d] a number of advantages achieved by the claimed cardiac monitoring device,” including more accurate and precise diagnosis of particular arrhythmias as compared to human doctors.[14]

    For defendants, consider pleading that the invention claims nothing more than long-known techniques in the Answer to the Complaint by attaching documents, declarations, or admissions to motions under Fed. R. Civ. P 12(b) or (c), or seeking judicial notice that the techniques practiced in the claimed invention are longstanding.[15] Otherwise, defendants are left to rely on an incomplete record that might not have sufficient evidence to mount an Alice defense based on automating longstanding practices.


    1. See Cardionet, LLC v. Infobionic Inc., Case No. 2019-1149 (Fed. Cir. 2020).
      [Back to reference]
    2. Id. at 3.
      [Back to reference]
    3. Id. at 6-7.
      [Back to reference]
    4. Id. at 13 (internal quotations omitted).
      [Back to reference]
    5. Id.
      [Back to reference]
    6. Id. at 17 (internal quotation omitted).
      [Back to reference]
    7. Id.
      [Back to reference]
    8. Id. at 14 (emphasis added) (internal quotation and citations omitted).
      [Back to reference]
    9. Id. at 15.
      [Back to reference]
    10. Id. at 16.
      [Back to reference]
    11. Id. at 18.
      [Back to reference]
    12. Id. at 16.
      [Back to reference]
    13. Id. at 17 (emphasis added); see also id. at 16.
      [Back to reference]
    14. Id. at 16-17.
      [Back to reference]
    15. Id. at 22, 29, 30.
      [Back to reference]

    Practices

    HealthcareDigital Health & TelemedicineLife SciencesIntellectual Property

    Industries

    Healthcare

    Insights And Happenings

    • Alert

      Guidance on electronic signatures at the USPTO

      Nov 7, 2020
    • Alert

      Update USPTO extends deadlines for applicants affected by the coronavirus

      June 30, 2020
    • Alert

      Electronic signatures in the coronavirus (COVID-19) era

      May 12, 2020
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved